scholarly journals Chemopreventive Effect of Aster glehni on Inflammation-Induced Colorectal Carcinogenesis in Mice

Nutrients ◽  
2018 ◽  
Vol 10 (2) ◽  
pp. 202 ◽  
Author(s):  
Kyung-Sook Chung ◽  
Se-Yun Cheon ◽  
Seong-Soo Roh ◽  
Minho Lee ◽  
Hyo-Jin An
2020 ◽  
Vol 11 (6) ◽  
pp. 4940-4952 ◽  
Author(s):  
Mingyue Song ◽  
Yaqi Lan ◽  
Xian Wu ◽  
Yanhui Han ◽  
Minqi Wang ◽  
...  

The inhibitory effect of dietary 5-demethylnobiletin on colitis-driven colorectal carcinogenesis and the potential roles of its colonic metabolites were reported.


2007 ◽  
Vol 18 (10) ◽  
pp. 1183-1187 ◽  
Author(s):  
Hiroyuki Kikuchi ◽  
Saburou Murakami ◽  
Satoe Suzuki ◽  
Hideki Kudo ◽  
Shuji Sassa ◽  
...  

2016 ◽  
Vol Volume 10 ◽  
pp. 2239-2253 ◽  
Author(s):  
Adel El-Shemi ◽  
Osama Kensara ◽  
Amr Mohamed ◽  
Bassem Refaat ◽  
Shakir Idris ◽  
...  

2010 ◽  
Vol 55 (2) ◽  
pp. 259-267 ◽  
Author(s):  
Isabel Villegas ◽  
Susana Sánchez-Fidalgo ◽  
Catalina Alarcón de la Lastra

Swiss Surgery ◽  
2003 ◽  
Vol 9 (1) ◽  
pp. 3-7 ◽  
Author(s):  
Gervaz ◽  
Bühler ◽  
Scheiwiller ◽  
Morel

The central hypothesis explored in this paper is that colorectal cancer (CRC) is a heterogeneous disease. The initial clue to this heterogeneity was provided by genetic findings; however, embryological and physiological data had previously been gathered, showing that proximal (in relation to the splenic flexure) and distal parts of the colon represent distinct entities. Molecular biologists have identified two distinct pathways, microsatellite instability (MSI) and chromosomal instability (CIN), which are involved in CRC progression. In summary, there may be not one, but two colons and two types of colorectal carcinogenesis, with distinct clinical outcome. The implications for the clinicians are two-folds; 1) tumors originating from the proximal colon have a better prognosis due to a high percentage of MSI-positive lesions; and 2) location of the neoplasm in reference to the splenic flexure should be documented before group stratification in future trials of adjuvant chemotherapy in patients with stage II and III colon cancer.


Planta Medica ◽  
2012 ◽  
Vol 78 (11) ◽  
Author(s):  
T Tanaka ◽  
S Genovese ◽  
T Kochi ◽  
F Epifano ◽  
L Scauri ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document